May 03, 2021 11:19 AM IST
CDSCO is responsible for approval of drugs, conduct of clinical trials, laying down the standards for drugs, control over the quality of imported drugs in the country and coordination of the activities of state drug control organisations.
- Jan 18, 2019 03:09 PM IST
Net Sales are expected to decrease by 5 percent Y-o-Y (down 1.8 percent Q-o-Q) to Rs. 534 crore, according to Sharekhan.
- Oct 17, 2018 11:28 AM IST
Net Sales are expected to increase by 20 percent Y-o-Y (down 4.9 percent Q-o-Q) to Rs. 512 crore, according to Sharekhan.
- May 11, 2017 08:11 AM IST
Hindalco | Inox Leisure | Tata Motors | Hero Motocorp | SML Isuzu | Quess Corp and Vakrangee are stocks, which are in news today.
- Jan 21, 2014 09:02 PM IST
A division bench of the Bombay HC, headed by Justice Oka, refused Bayer‘s plea to place the matter before the court for urgent hearing. In a brief order passed today, the division bench cited several pending cases and disregarded the urgency cited by Bayer.
- Mar 20, 2013 08:34 AM IST
Asian Paints | Lloyds Steel | 3M India | PNB | IFCI | SAIL | Natco Pharma | M&M and Bharti Airtel are stocks, which are in the news today.
- Oct 19, 2012 11:35 AM IST
Rigorous research has been the backbone of ICICI Prudential's decisions to go against the mutual fund tide, and emerge successful.
- Sep 20, 2012 10:09 PM IST
German drugmaker Bayer may be fighting it out in the courtroom to defend its patent rights on cancer drug Nexavar. But out in the market, it's already lost considerable market share to cheaper variants from Cipla and Natco.
- Aug 17, 2012 09:54 PM IST
CNBC-TV18's Archana Shukla reports that India's grant of a compulsory licence to Natco for Bayer's kidney-cancer drug Nexavar has sent shockwaves across the globe
- Aug 16, 2012 09:41 PM IST
By granting compulsory license to Natco for Bayer's kidney cancer drug Nexavar, the Indian government has opened a legal can of worms, reports CNBC-TV18's Archana Shukla.
- Aug 14, 2012 09:57 PM IST
Compulsory license granted to Natco has left the Indian pharma industry with a hard choice to make - cut prices, or quit selling the drug. To counter this drug-makers are changing strategies, reports CNBC-TV18's Archana Shukla.
- Mar 20, 2012 12:09 PM IST
By: Rahul Dhote & Mita Sheikh, Krishna & Saurastri
- Feb 10, 2011 08:20 AM IST
Gitanjali Gems | Natco | TIL | GVK | Reliance Infrastructure | TCS | Mahindra Composites | Gujarat Pipavav | Punj Lloyd | SAIL and M&M are stocks, which are in the news today.